Certain Common Shares of Mizuho Medy Co.,Ltd. are subject to a Lock-Up Agreement Ending on 13-JUN-2016.
June 12, 2016
Share
Certain Common Shares of Mizuho Medy Co.,Ltd. are subject to a Lock-Up Agreement Ending on 13-JUN-2016. These Common Shares will be under lockup for 180 days starting from 16-DEC-2015 to 13-JUN-2016.
Details:
The shareholders of the company, Lo Chinyu, Fuminari Kawakawa, Mizuho Medy employee shareholding commission, Noriyasu Karakawa, Masahiro Yamasato, The Nishi-Nippon City Bank, Ltd., Kameshiro Watanabe, Kazuya Yamaguchi, Sadanori Tateiishi, Takako Karakawa, Mika Karakawa, Kenji Narahara, Kimie Karakawa, Kazuhiro Ichimaru, Tadashi Imamura, Hiroshi Sasaki, and Toshio Kamihara, have agreed not to dispose of any shares of the company, for a period of 180 days from the listing date, December 17, 2015.
MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
MIZUHO MEDY CO.,LTD. 
